Abramson Cancer Center of the University of Pennsylvania
Last Modified: June 4, 2007
Weijing Sun, MD at the Wanjie Hospital Proton Therapy Center
Gantry Treatment Room at the Wanjie Hospital Proton Therapy Center
Fixed Beam Treatment Room at the Wanjie Hospital Proton Therapy Center
Mar 4, 2015 - Long-term survival may be increased in medium-risk prostate cancer patients who receive short-term androgen deprivation therapy before and during radiation treatment compared with men who receive radiation alone. In addition, proton beam therapy may be associated with a decreased risk of disease recurrence after 10 years and has minimal side effects after one year, according to research presented at the 51st Annual Meeting of the American Society for Radiation Oncology, held from Nov. 1 to 5 in Chicago.